Gravis Myasthenia Information

Diseases

Arthritis
Asthma
Backpain
Diabetes
Heart Attack
High Blood Pressure
Headache
Migraine
Depression
Disorders

General Ailments
Blood Disorders
Digestive Disorders
Gastroenterology Disorders
Respiratory Disorders
Fevers
Gynacological Conditions
Cardiology Diseases
Neurology Diseases
Cardiovascular Diseases
Medication

Medication Library: Information listing all medication & drugs in Albhabatical Order. Learn More..
Mental Health

Your complete mental health care guide, all information on metal disorders. Learn More..
Home Remedies

Treatment and Cure of all ailments and health disorders by natural homemade remedies by experts. Learn More..
Health Articles

Health & Executive
Life & Health
Health & Happiness
Heart Health
Lung Health
Dental Health
Eye Care
Stress & Strain
Your Health Diet
Fitness & Exercise
Planning For Well-Being

 

Home :: Diseases :: Gravis Myasthenia
 

Gravis Myasthenia Information - symptom, cause, picture, treatment of Gravis Myasthenia

Gravis Myasthenia Information

Myasthenia gravis occurs at all ages, sometimes in association with a thymic tumor or thyrotoxicosis, as well as in rheumatoid arthritis and lupus erythematosus. It is commonest in young women with HLA-DR3; if thymoma is associated, older men are more commonly affected. Onset is usually insidious, but the disorder is sometimes unmasked by a coincidental infection that leads to exacerbation of symptoms. Exacerbations may also occur before the menstrual period and during or shortly after pregnancy. Symptoms are due to a variable degree of block of neuromuscular transmission caused by autoantibodies binding to acetylcholine receptors; these are found in most patients with the disease and have a primary role in reducing the number of functioning acetylcholine receptors. Additionally, cellular immune activity against the receptor is found. Clinically, this leads to weakness; initially powerful movements fatigue readily. The external ocular muscles and certain other cranial muscles, including the masticatory, facial, and pharyngeal muscles, are especially likely to be affected, and the respiratory and limb muscles may also be involved.

Symptoms and Signs of Gravis Myasthenia

Patients present with ptosis, diplopia, difficulty in chewing or swallowing, respiratory difficulties, limb weakness, or some combination of these problems. Weakness may remain localized to a few muscle groups, especially the ocular muscles, or may become generalized. Symptoms often fluctuate in intensity during the day, and this diurnal variation is superimposed on a tendency to longer-term spontaneous relapses and remissions that may last for weeks. Nevertheless, the disorder follows a slowly progressive course and may have a fatal outcome owing to respiratory complications such as aspiration pneumonia.

Clinical examination confirms the weakness and fatigability of affected muscles. In most cases, the extraocular muscles are involved, and this leads to ocular palsies and ptosis, which are commonly asymmetric. Pupillary responses are normal. The bulbar and limb muscles are often weak, but the pattern of involvement is variable. Sustained activity of affected muscles increases the weakness, which improves after a brief rest. Sensation is normal, and there are usually no reflex changes.

Treatment of Gravis Myasthenia

Medication such as aminoglycosides that may exacerbate myasthenia gravis should be avoided. Anticholinesterase drugs provide symptomatic benefit without influencing the course of the disease. Neostigmine, pyridostigmine, or both can be used, the dose being determined on an individual basis. The usual dose of neostigmine is 7.5–30 mg (average, 15 mg) taken four times daily; of pyridostigmine, 30–180 mg (average, 60 mg) four times daily. Overmedication may temporarily increase weakness, which is then unaffected or enhanced by intravenous edrophonium.

Thymectomy usually leads to symptomatic benefit or remission and should be considered in all patients younger than age 60, unless weakness is restricted to the extraocular muscles. If the disease is of recent onset and only slowly progressive, operation is sometimes delayed for a year or so, in the hope that spontaneous remission will occur.

Treatment with corticosteroids is indicated for patients who have responded poorly to anticholinesterase drugs and have already undergone thymectomy. It is introduced with the patient in the hospital, since weakness may initially be aggravated. Once weakness has stabilized after 2–3 weeks or any improvement is sustained, further management can be on an outpatient basis. Alternate-day treatment is usually well tolerated, but if weakness is enhanced on the nontreatment day it may be necessary for medication to be taken daily. The dose of corticosteroids is determined on an individual basis, but an initial high daily dose (eg, prednisone, 60–100 mg) can gradually be tapered to a relatively low maintenance level as improvement occurs; total withdrawal is difficult, however. Treatment with azathioprine may also be effective. The usual dose is 2–3 mg/kg orally daily after a lower initial dose.

 

 

Health Home Health Blog Health Resources Policy & Terms Advertise With Us Contact Us

Your feedback and queries are greatly appreciated, keep them coming here..
© www.diseasesatoz.com All Rights Reserved.


Disclaimer: All information on www.diseasesatoz.com is for educational purposes only. It is not a substitute for professional medical advice. For specific medical advice, diagnoses, and treatment, please consult your doctor.